Filing Details

Accession Number:
0001615774-16-007910
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-31 16:35:46
Reporting Period:
2016-10-31
Filing Date:
2016-10-31
Accepted Time:
2016-10-31 16:35:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346251 B John Rhodes C/O Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2016-10-31 25,000 $0.00 137,196 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant Acquisiton 2016-10-31 25,000 $0.00 12,500 $0.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2016-10-31 2021-10-31 No 4 P Direct
Footnotes
  1. Included in the purchase of 100,000 Units at a price of $0.55 per Unit. Each Unit consisted of one share of common stock and one warrant exercisable immediately for one-half (0.50) share of common stock at an exercise price of $0.63 per share.